Anti-COMMD9 antibody produced in rabbit

COMMD9 (copper metabolism domain containing 9) is widely expressed in kidney, and in renal collecting duct cells, it colocalizes with epithelial sodium channel (ENaC). It belongs to the 10-member protein family called COMMD.

COMM domain-containing protein 9 recombinant protein epitope signature tag (PrEST)

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

In mammalian epithelia, COMMD9 (copper metabolism domain containing 9) causes a suppression in the expression of epithelial sodium channel (ENaC) and also results in reduced amiloride-sensitive current. This protein might thus be responsible for regulating the cell surface expression of ENaC, thereby controlling Na⁺ transport. The function of this protein is not yet very clear, but it interacts with NF-κB and suppresses NF-κB-mediated transcription. This protein interacts with Notch receptor family proteins and CCC subunits, and in cells lacking COMMD9 protein, Notch family receptors are retained in endosomes and eventually degraded by lysosomes. Inactivation of this gene in mouse leads to embryo fatality and complex cardiovascular changes.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Corresponding Antigen APREST71484

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany